Silent Drug Therapy Problems Caused by Over-The-Counter Medicines: A Clinical Pharmacy Perspective

Modern self-care relies heavily on over-the-counter (OTC) medications, which are frequently used to treat minor illnesses without a doctor's direct supervision. Despite the widespread belief that these drugs are safe, there is mounting evidence that improper use of over-the-counter (OTC) pharmaceuticals significantly contributes to drug-related disorders (DRPs), which frequently go unreported and stay clinically quiet. From a clinical pharmacy viewpoint, this narrative review investigates the kind, prevalence, and clinical importance of silent drug treatment issues related to over-the-counter medications. Inappropriate self-diagnosis, improper product selection, excessive dosage or prolonged use, therapeutic duplication, unidentified contraindications, drug–drug interactions, and misuse or abuse—particularly with regard to high-risk drug classes like analgesics, cough and cold remedies, antihistamines, and combination products—are among the major problems found. The analysis also identifies significant obstacles to OTC safety monitoring, such as inadequate recording of nonprescription medication usage, a lack of expert oversight, and methodological flaws in pharmacovigilance systems. Pharmacists are ideally positioned to identify, prevent, and resolve most OTC-related DRPs through systematic evaluation, patient counselling, and prompt intervention, frequently before clinical damage occurs, according to evidence from community pharmacy practice. The results highlight the necessity of implementing standardised counselling models, improving safety surveillance systems, strengthening pharmacist education in nonprescription pharmacotherapy, and formally including OTC drugs into thorough medication reviews. In a time when self-medication is becoming more common, it is crucial to acknowledge over-the-counter medications as pharmacologically active agents rather than naturally harmless goods in order to lower avoidable morbidity and enhance patient safety.

Over-the-counter medicines, drug-related problems, self-medication, clinical pharmacy, medication safety, pharmacist intervention, pharmacovigilance

1. Panditrao, M. M. (2025). To be over-the-counter or not to be–That is the question: Reconsidering overthe-counter access–When convenience becomes a public health risk. [Google Scholar] [Crossref]

2. Noah, L. (2018). Reversal of Fortune: Moving Pharmaceuticals from over-the-Counter to Prescription Status. Vill. L. Rev., 63, 355. [Google Scholar] [Crossref]

3. Levy, H. B. (2023). Maybe It's Your Medications: How to Avoid Unnecessary Drug Therapy and Adverse Drug Reactions. Simon and Schuster. [Google Scholar] [Crossref]

4. McKee, P., Hughes, C., & Hanna, L. A. (2015). Views of pharmacy graduates and pharmacist tutors on evidence‐based practice in relation to over‐the‐counter consultations: a qualitative study. Journal of evaluation in clinical practice, 21(6), 1040-1046. [Google Scholar] [Crossref]

5. Eickhoff, C., Hämmerlein, A., Griese, N., & Schulz, M. (2012). Nature and frequency of drug‐related problems in self‐medication (over‐the‐counter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiology and drug safety, 21(3), 254-260. [Google Scholar] [Crossref]

6. Hammad, E. A., Elayeh, E., Tubeileh, R., Watson, M., & Wazaify, M. (2018). A simulated patient study assessing over the counter supply and counseling in Jordan: responding to headache complaints. International Journal of Clinical Pharmacy, 40(5), 982-986. [Google Scholar] [Crossref]

7. Hockenhull, J., Wood, D. M., Fonseca, F., Guareschi, M., Scherbaum, N., Iwanicki, J. L., ... & Dargan, P. I. (2022). The association between the availability of over the counter codeine and the prevalence of nonmedical use. European Journal of Clinical Pharmacology, 78(6), 1011-1018. [Google Scholar] [Crossref]

8. Stosic, R., Dunagan, F., Palmer, H., Fowler, T., & Adams, I. (2011). Responsible self-medication: perceived risks and benefits of over-the-counter analgesic use. International Journal of Pharmacy Practice, 19(4), 236-245. [Google Scholar] [Crossref]

9. Ylä-Rautio, H., Siissalo, S., & Leikola, S. (2020). Drug-related problems and pharmacy interventions in non-prescription medication, with a focus on high-risk over-the-counter medications. International journal of clinical pharmacy, 42(2), 786-795. [Google Scholar] [Crossref]

10. Ma, C., & Zhang, H. (2025). A cross-sectional study on self-medication with over-the-counter drugs among adolescents: an analysis of current practices. Frontiers in public health, 13, 1560299. [Google Scholar] [Crossref]

11. Eickhoff C, Hämmerlein A, Griese N, Schulz M. Nature and frequency of drug-related problems in selfmedication (over-thecounter drugs) in daily community pharmacy practice in Germany. Pharmacoepidemiol Drug Saf. 2012;21:254–60. [Google Scholar] [Crossref]

12. Mullan J, Weston KM, Bonney A, Burns P, Mullan J, Rudd R. Consumer knowledge about over-thecounter NSAIDs: they don’t know what they don’t know. Aust NZ J Public Health. 2017;41:210–4. [Google Scholar] [Crossref]

13. Sansgiry, S. S., Bhansali, A. H., Bapat, S. S., & Xu, Q. (2016). Abuse of over-the-counter medicines: a pharmacist’s perspective. Integrated Pharmacy Research and Practice, 1-6. [Google Scholar] [Crossref]

14. Ngcobo, N. N. (2025). Silent Dangers in Elderly Pharmacotherapy: The Interplay of Polypharmacy, Multimorbidity, and Drug Interactions. Journal of Evaluation in Clinical Practice, 31(7), e70283. [Google Scholar] [Crossref]

15. Sansgiry SS, Nadkarni A, Doan T. Misuse of over-the-counter medications among community-dwelling older adults and associated adverse drug events. J Pharmaceutical Health Serv Res. 2010;1(4):175–179. [Google Scholar] [Crossref]

16. Cooper, R. J. (2013). Over-the-counter medicine abuse–a review of the literature. Journal of substance use, 18(2), 82-107. [Google Scholar] [Crossref]

17. Wazaify, M., Shields, E., Hughes, C. M., & McElnay, J. C. (2005). Societal perspectives on over-thecounter (OTC) medicines. Family Practice, 22(2), 170–171. [Google Scholar] [Crossref]

18. Vitic, J., Yakiwchuk, E., & Crawley, A. (2023). Improper administration: Silent culprit of drug therapy problems. Canadian Family Physician, 69(2), 107-112. [Google Scholar] [Crossref]

19. Scottish Specialist in Pharmaceutical Public Health. (2004). Drugs misuse and community pharmacy: Issues for pharmaceutical care. Scotland: Scottish Specialist in Pharmaceutical Public Health [Google Scholar] [Crossref]

20. Robinson, G. M., Robinson, S., McCarthy, P., & Cameron, C. (2010). Misuse of over-the-counter codeinecontaining analgesics: Dependence and other adverse effects. New Zealand Medical Journal, 123(1317), 59–64 [Google Scholar] [Crossref]

21. Frøkjær, B., Bolvig, T., Griese, N., Herborg, H., & Rossing, C. (2012). Prevalence of drug-related problems in self-medication in Danish community pharmacies. INNOVATIONS in pharmacy, 3(4).. [Google Scholar] [Crossref]

22. Kamal, M., Negm, W. A., Abdelkader, A. M., Alshehri, A. A., Batiha, G., & Osama, H. (2023). Most common over-the-counter medications and effects on patients. European Review for Medical & Pharmacological Sciences, 27(4). [Google Scholar] [Crossref]

23. Abood, E. A., Scott, J., & Wazaify, M. (2018). User experiences of prescription and over-the-counter drug abuse in Aden City, Yemen. Pharmacy, 6(3), 99. [Google Scholar] [Crossref]

24. Anghel, I. B., & Craciun, C. (2013). Self-medication with over-the-counter drugs and antibiotics in Romanian consumers: a qualitative study. Cognition, Brain, Behavior, 17(3), 215. [Google Scholar] [Crossref]

25. Adhikari, B., Pokharel, S., Raut, S., Adhikari, J., Thapa, S., Paudel, K., ... & Pell, C. (2021). Why do people purchase antibiotics over-the-counter? A qualitative study with patients, clinicians and dispensers in central, eastern and western Nepal. BMJ global health, 6(5), e005829. [Google Scholar] [Crossref]

26. Berenbrok, L. A., Ciemniecki, L., Cremeans, A. A., Albright, R., & Mormer, E. (2021). Pharmacist competencies for over-the-counter hearing aids: A Delphi study. Journal of the American Pharmacists Association, 61(4), e255-e262. [Google Scholar] [Crossref]

27. Alenezi, A., Yahyouche, A., & Paudyal, V. (2022). Roles, barriers and behavioral determinants related to community pharmacists' involvement in optimizing opioid therapy for chronic pain: a qualitative study. International Journal of Clinical Pharmacy, 44(1), 180-191. [Google Scholar] [Crossref]

• QbD Approach to Hplc Method Development and Validation of the Simultaneous Estimation of Sulbactum and Durlobactum in Pharmaceutical Dosage Form
• A Review on an Evaluation of a Liposomal Hydrogel for Combined Minoxidil and Tretinoin Delivery in Androgenetic Alopecia
• Qualitative Screening and Analysis of Lunasia amara Blanco (Tawal-ulad) Ethanolic Leaves Extract as Potential Anti-Angiogenic Inhibitors Using the Chorioallantoic Membrane Assay on Mallard Duck Embryo
• A Comprehensive Review on Calotropis Procera on Its Analgesic Activity
• Formulation, Characterization and In-Vitro Evaluation of Curcumin Loaded Liposome for Colon Drug delivery